March 29, 2016 — IBA (Ion Beam Applications S.A.) announced the sale of IBA Molecular (IBAM) in which IBA had a 40 ...
March 14, 2016 — Writing in the March 14 online issue of Nature Materials, researchers at University of California, San ...
March 1, 2016 — Wisconsin-based Shine Medical Technologies Inc., producer of medical tracers and cancer treatment ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
February 23, 2016 — The National Institutes of Health recently bestowed a $1.5 million grant on a Washington University ...
February 18, 2016 — Navidea Biopharmaceuticals Inc. last week announced that the first patient has been enrolled in a ...
February 18, 2016 — Manhattan Scientifics Inc. announced its wholly-owned subsidiary Senior Scientific LLC, which is ...
Technology advancements are changing consumers’ expectations, driving industries to adapt and evolve, and the healthcare ...
February 3, 2016 — The nuclear medicine, proton therapy and brachytherapy markets represent less than 0.1 percent of ...
January 29, 2016 — A biochemical compound developed as a radioactive tracer for cell proliferation shows increasing ...
January 26, 2016 — University of Missouri researcher Silvia Jurisson and her interdisciplinary team recently received a ...
January 21, 2016 — Researchers at Thomas Jefferson University have found the method they developed to image the prostate ...
Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on cancer diagnostics and ...
December 11, 2015 — Navidea Biopharmaceuticals Inc. announced that results from an investigator-initiated imaging study ...
November 3, 2015 — Australian immuno-oncology company Minomic International Ltd has struck an agreement to launch the ...
October 19, 2015 — Siemens’ PETNET Solutions Inc., a wholly owned subsidiary of Siemens Healthcare, will formulate the ...
October 2, 2015 — Siemens’ PETNET Solutions has received Abbreviated New Drug Application (ANDA) approval from the U.S ...
September 23, 2015 — New research describes a method, tested in rats, that may someday allow healthcare providers to ...
September 18, 2015 — A recently developed drug was significantly better at detecting recurring prostate cancer in early ...
September 17, 2015 — At the National Nuclear Security Administration’s (NNSA) 2015 Mo-99 Topical Meeting, Novation ...
September 16, 2015 — A novel radiopharmaceutical probe developed at Massachusetts General Hospital (MGH) has the ...
September 14, 2015 — ImaginAb Inc. has released interim results from a Phase 2 clinical trial of IAB2M, the company's ...